Meiji Seika Pharma to Transfer 3 Generic Brands to Its Generic Subsidiary

Meiji Seika Pharma announced on August 1 that it will transfer the marketing authorization for three generic brands to its generic subsidiary Me Pharma. Me Pharma will take over on September 29 the marketing authorization for atorvastatin tablets, valsartan tablets,...read more